Showing results (81-90 of 130) with videos related to

Sort By:
Pageof 13
Case Reports in Gastroenterology|November 25, 2010
Autoimmune Hepatitis and Celiac Disease: Case Report Showing an Entero-Hepatic LinkFrancesco Tovoli, Roberto De Giorgio, Giacomo Caio, et al.
Cancers|March 11, 2023
Prognostic Impact of Metastatic Site in Patients Receiving First-Line Sorafenib Therapy for Advanced Hepatocellular CarcinomaLuca Ielasi, Francesco Tovoli, Matteo Tonnini, et al.
Cancers|December 24, 2021
Beneficial Prognostic Effects of Aspirin in Patients Receiving Sorafenib for Hepatocellular Carcinoma: A Tale of Multiple ConfoundersLuca Ielasi, Francesco Tovoli, Matteo Tonnini, et al.
The American Journal of Gastroenterology|August 26, 2025
TIMING THE SCAN: OPTIMIZING SCREENING FOR OSTEOPOROSIS AND RISK OF FRACTURE IN CELIAC DISEASEFrancesco Tovoli, Guido Zavatta, Giovanni Monaco, et al.
United European Gastroenterology Journal|February 22, 2019
Imaging of combined hepatocellular-cholangiocarcinoma in cirrhosis and risk of false diagnosis of hepatocellular carcinomaElisabetta Sagrini, Massimo Iavarone, Federico Stefanini, et al.
Journal of Hepatocellular Carcinoma|April 3, 2023
Presence of Hepatocellular Carcinoma Does Not Affect Course and Response to Anticoagulation of Bland Portal Vein Thrombosis in Cirrhotic PatientsFrancesca Benevento, Anna Pecorelli, Horia Stefanescu, et al.
Medical Oncology (Northwood, London, England)|March 14, 2020
Ablation for hepatocellular carcinoma: beyond the standard indicationsMatteo Renzulli, Francesco Tovoli, Alfredo Clemente, et al.
European Journal of Immunology|November 22, 2023
Circulating CD8 lymphocytes predict response to atezolizumab-bevacizumab in hepatocellular carcinomaLaura Gramantieri, Fabrizia Suzzi, Cristian Bassi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 26, 2021
Pattern of progression of intrahepatic cholangiocarcinoma: Implications for second-line clinical trialsFrancesco Tovoli, Ingrid Garajová, Fabio Gelsomino, et al.
European Radiology|April 11, 2018
Inter-operator variability and source of errors in tumour response assessment for hepatocellular carcinoma treated with sorafenibFrancesco Tovoli, Matteo Renzulli, Giulia Negrini, et al.
Pageof 13